CurrentEndo
Get Weekly

Topic · page 101 of 119

Type 2 & other diabetes

Type 2 diabetes and prediabetes: prevention, remission, glucose-lowering drugs, weight-based treatment, insulin, lifestyle and diet; monogenic and other specific types of diabetes

Briefs 4,001–4,040 of 4,758 placed here, newest publication first

Briefs in Type 2 & other diabetes

Newest publication first

  1. Diabetes Obes Metab

    Trajectories of fasting glucose and glycated haemoglobin in obese and non‐obese incident diabetes: Results from two large cohort studies

    Cohort study

  2. Diabetes Res Clin Pract

    Effect of vitamin D on regression to normal glucose regulation and individual glycemic measures: A secondary analysis among participants adherent to the trial protocol in the randomized clinical trial vitamin D and type 2 diabetes (D2d) study

    Secondary analysis

  3. J Clin Endocrinol Metab

    Expression of Secretin and its Receptor Along the Intestinal Tract in Type 2 Diabetes Patients and Healthy Controls

    Mechanistic study

  4. Diabetes Obes Metab

    A prediction model on incident chronic kidney disease among individuals with type 2 diabetes in the United States

    Diagnostic or prognostic study

  5. Diabetes Obes Metab

    Crosstalk between genetic variability of adiponectin and leptin, glucose‐insulin system and subclinical atherosclerosis in patients with newly diagnosed type 2 diabetes. The Verona Newly Diagnosed Type 2 Diabetes Study 14

    Cross-sectional study

  6. Diabetes Obes Metab

    Serum uric acid lowering and effects of sodium‐glucose cotransporter‐2 inhibitors on gout: A meta‐analysis and meta‐regression of randomized controlled trials

    Meta-analysis

  7. Diabetes Obes Metab

    Real‐world study of ethnic differences in glycaemic control and clinical characteristics among insulin‐naïve people with type 2 diabetes initiating biphasic insulin aspart 30/70: A retrospective, observational cohort study in England

    Cohort study

  8. Diabetes Obes Metab

    Safety/tolerability, efficacy and pharmacokinetics of 600‐μg cotadutide in Japanese type 2 diabetes patients with a body mass index of 25 kg/m 2 or higher: A phase I, randomized, double‐blind, placebo‐controlled study

    Randomized controlled trial

  9. Diabetologia

    Plasma proteomic signatures of a direct measure of insulin sensitivity in two population cohorts

    Cross-sectional study

  10. BMJ Open Diabetes Res Care

    Prevalence and predictive modeling of undiagnosed diabetes and impaired fasting glucose in Taiwan: a Taiwan Biobank study

    Cross-sectional study

  11. BMJ Open Diabetes Res Care

    Efficacy and safety of luseogliflozin in Caucasian patients with type 2 diabetes: results from a phase III, randomized, placebo-controlled, clinical trial

    Randomized controlled trial

  12. Cardiovasc Diabetol

    Identification of candidate metabolite biomarkers for metabolic syndrome and its five components in population-based human cohorts

    Cohort study

  13. Cardiovasc Diabetol

    Cardiovascular mortality in patients with advanced chronic kidney disease with and without diabetes: a nationwide cohort study

    Cohort study

  14. Diabet Med

    Optimal staffing for a good quality inpatient diabetes service

    Cross-sectional study

  15. Diabetes Care

    Insulin Use in Type 2 Diabetes and the Risk of Dementia: A Comparative Population-Based Cohort Study

    Cohort study

  16. Cardiovasc Diabetol

    Machine learning-based models to predict one-year mortality among Chinese older patients with coronary artery disease combined with impaired glucose tolerance or diabetes mellitus

    Diagnostic or prognostic study

  17. Diabetes Res Clin Pract

    Longitudinal treatment patterns in patients recently diagnosed with type 2 diabetes mellitus in Catalonia

    Cohort study

  18. Diabetes Obes Metab

    Liver fibrosis markers and all cause mortality in people with type 2 diabetes: A population based study (The Ayrshire Diabetes Outcomes Cohort (ADOC) Study)

    Cohort study

  19. Diabetes Obes Metab

    Tolerability, safety and pharmacodynamics of oral, small‐molecule glucagon‐like peptide‐1 receptor agonist danuglipron for type 2 diabetes: A 12‐week, randomized, placebo‐controlled, Phase 2 study comparing different dose‐escalation schemes

    Randomized controlled trial

  20. Diabetes Obes Metab

    Effects of dietary quality, physical activity and weight loss on glucose homeostasis in persons with and without prediabetes in the PREMIER trial

    Secondary analysis

  21. Diabetes Obes Metab

    Neighbourhood‐level social deprivation and the risk of recurrent heart failure hospitalizations in type 2 diabetes

    Cohort study

  22. BMJ Open Diabetes Res Care

    Cardiorenal protective effects of canagliflozin in CREDENCE according to glucose lowering

    Secondary analysis

  23. Diabetologia

    Hypoglycaemia frequency and physiological response after double or triple doses of once-weekly insulin icodec vs once-daily insulin glargine U100 in type 2 diabetes: a randomised crossover trial

    Randomized controlled trial

  24. Obesity (Silver Spring)

    Age‐ and sex‐specific changes in visceral fat mass throughout the life‐span

    Cross-sectional study

  25. Diabetologia

    Associations of plasma proteomics with type 2 diabetes and related traits: results from the longitudinal KORA S4/F4/FF4 Study

    Cohort study

  26. Diabetes Obes Metab

    Comparative efficacy and safety of Gla‐300 versus IDegAsp in insulin‐naïve people with type 2 diabetes mellitus uncontrolled on oral anti‐diabetics

    Meta-analysis

  27. Diabetes Obes Metab

    Respiratory effort during sleep and the rate of prevalent type 2 diabetes in obstructive sleep apnoea

    Cross-sectional study

  28. Diabetes Obes Metab

    Risk of breakthrough SARS‐CoV‐2 infection and clinical outcomes among vaccinated patients with type 2 diabetes

    Cohort study

  29. Diabetes Care

    Common and Distinct Genetic Architecture of Age at Diagnosis of Diabetes in South Indian and European Populations

    Meta-analysis

  30. Cardiovasc Diabetol

    Normal-weight visceral obesity promotes a higher 10-year atherosclerotic cardiovascular disease risk in patients with type 2 diabetes mellitus–a multicenter study in China

    Cross-sectional study

  31. Cardiovasc Diabetol

    Development of a biomarker panel for assessing cardiovascular risk in diabetic patients with chronic limb-threatening ischemia (CLTI): a prospective study

    Cohort study

  32. Diabetes Res Clin Pract

    Magnetic resonance study of visceral, subcutaneous, liver and pancreas fat changes after 12 weeks intermittent fasting in obese participants with prediabetes

    Secondary analysis

  33. Diabetologia

    Birthweight is associated with clinical characteristics in people with recently diagnosed type 2 diabetes

    Cross-sectional study

  34. Diabet Med

    Effects of DPP‐4 inhibitors, GLP‐1 receptor agonists, SGLT‐2 inhibitors and sulphonylureas on mortality, cardiovascular and renal outcomes in type 2 diabetes: A network meta‐analyses‐driven approach

    Meta-analysis

  35. Diabetes Obes Metab

    Impact of pre‐existing type 2 diabetes with and without cardiovascular disease on patients with COVID ‐19

    Cohort study

  36. Diabetologia

    Low birthweight is associated with a higher incidence of type 2 diabetes over two decades independent of adult BMI and genetic predisposition

    Cohort study

  37. Diabetes Res Clin Pract

    Type 2 diabetes stigma and its association with clinical, psychological, and behavioral outcomes: A systematic review and meta-analysis

    Meta-analysis

  38. Diabetologia

    Interaction between plasma phospholipid odd-chain fatty acids and GAD65 autoantibodies on the incidence of adult-onset diabetes: the EPIC-InterAct case–cohort study

    Cohort study

  39. BMJ Open Diabetes Res Care

    Patients with prediabetes are at greater risk of developing diabetes 5 months postacute SARS-CoV-2 infection: a retrospective cohort study

    Cohort study

  40. Cardiovasc Diabetol

    The change of triglyceride-glucose index may predict incidence of stroke in the general population over 45 years old

    Cohort study

All 4,758 Briefs in ExploreShowing Briefs 4,001–4,040 of 4,758, newest first